喵ID:VRAPDl免责声明

GATA Factor-Dependent Positive-Feedback Circuit in Acute Myeloid Leukemia Cells.

基本信息

DOI:
10.1016/j.celrep.2016.07.058
发表时间:
2016-08-30
期刊:
影响因子:
8.8
通讯作者:
Bresnick EH
中科院分区:
生物学1区
文献类型:
Journal Article
作者: Katsumura KR;Ong IM;DeVilbiss AW;Sanalkumar R;Bresnick EH研究方向: -- MeSH主题词: --
关键词: --
来源链接:pubmed详情页地址

文献摘要

The master regulatory transcription factor GATA-2 triggers hematopoietic stem and progenitor cell generation. GATA2 haploinsufficiency is implicated in myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML), and GATA2 overexpression portends a poor prognosis for AML. However, the constituents of the GATA-2-dependent genetic network mediating pathogenesis are unknown. We described a p38-dependent mechanism that phosphorylates GATA-2 and increases GATA-2 target gene activation. We demonstrate that this mechanism establishes a growth-promoting chemokine/cytokine circuit in AML cells. p38/ERK-dependent GATA-2 phosphorylation facilitated positive autoregulation of GATA2 transcription and expression of target genes, including IL1B and CXCL2. IL-1β and CXCL2 enhanced GATA-2 phosphorylation, which increased GATA-2-mediated transcriptional activation. p38/ERK-GATA-2 stimulated AML cell proliferation via CXCL2 induction. As GATA2 mRNA correlated with IL1B and CXCL2 mRNAs in AML-M5 and high expression of these genes predicted poor prognosis of cyto-genetically normal AML, we propose that the circuit is functionally important in specific AML contexts. Katsumura et al. uncover a signaling mechanism that amplifies GATA-2 activity at select target genes in acute myeloid leukemia cells. Expression of GATA-2 target genes encoding the chemokine CXCL2 and cytokine IL-1β correlates with GATA-2 expression in a subtype of human AML, and high GATA-2/CXCL2 expression predicts poor prognosis.
主调控转录因子GATA - 2触发造血干细胞和祖细胞的产生。GATA2单倍体不足与骨髓增生异常综合征(MDS)和急性髓系白血病(AML)有关,并且GATA2过表达预示着AML预后不良。然而,介导发病机制的依赖于GATA - 2的基因网络的组成成分尚不清楚。我们描述了一种依赖于p38的机制,该机制使GATA - 2磷酸化并增加GATA - 2靶基因的激活。我们证明这种机制在AML细胞中建立了一个促进生长的趋化因子/细胞因子回路。p38/ERK依赖的GATA - 2磷酸化促进了GATA2转录的正反馈调节以及包括IL1B和CXCL2在内的靶基因的表达。IL - 1β和CXCL2增强了GATA - 2的磷酸化,这增加了GATA - 2介导的转录激活。p38/ERK - GATA - 2通过CXCL2的诱导刺激AML细胞增殖。由于在AML - M5中GATA2 mRNA与IL1B和CXCL2 mRNAs相关,并且这些基因的高表达预示着细胞遗传学正常的AML预后不良,我们提出该回路在特定的AML环境中具有重要的功能。 Katsumura等人揭示了一种在急性髓系白血病细胞中特定靶基因上放大GATA - 2活性的信号传导机制。在人类AML的一个亚型中,编码趋化因子CXCL2和细胞因子IL - 1β的GATA - 2靶基因的表达与GATA - 2的表达相关,并且高GATA - 2/CXCL2表达预示着预后不良。
参考文献(0)
被引文献(0)
Master regulatory GATA transcription factors: mechanistic principles and emerging links to hematologic malignancies.
DOI:
10.1093/nar/gks281
发表时间:
2012-07
期刊:
Nucleic acids research
影响因子:
14.9
作者:
Bresnick EH;Katsumura KR;Lee HY;Johnson KD;Perkins AS
通讯作者:
Perkins AS
Antibodies targeting human IL1RAP (IL1R3) show therapeutic effects in xenograft models of acute myeloid leukemia
DOI:
10.1073/pnas.1422749112
发表时间:
2015-08-25
期刊:
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
影响因子:
11.1
作者:
Agerstam, Helena;Karlsson, Christine;Fioretos, Thoas
通讯作者:
Fioretos, Thoas
Genome-wide analysis of transcriptional regulators in human HSPCs reveals a densely interconnected network of coding and noncoding genes
DOI:
10.1182/blood-2013-03-490425
发表时间:
2013-10-03
期刊:
BLOOD
影响因子:
20.3
作者:
Beck, Dominik;Thoms, Julie A. I.;Pimanda, John E.
通讯作者:
Pimanda, John E.
Mutations in KIT and RAS are frequent events in pediatric core-binding factor acute myeloid leukemia
DOI:
10.1038/sj.leu.2403870
发表时间:
2005-09-01
期刊:
LEUKEMIA
影响因子:
11.4
作者:
Goemans, BF;Zwaan, CM;Heinrich, MC
通讯作者:
Heinrich, MC
Cancer and the chemokine network
DOI:
10.1038/nrc1388
发表时间:
2004-07-01
期刊:
NATURE REVIEWS CANCER
影响因子:
78.5
作者:
Balkwill, F
通讯作者:
Balkwill, F

数据更新时间:{{ references.updateTime }}

Bresnick EH
通讯地址:
--
所属机构:
--
电子邮件地址:
--
免责声明免责声明
1、猫眼课题宝专注于为科研工作者提供省时、高效的文献资源检索和预览服务;
2、网站中的文献信息均来自公开、合规、透明的互联网文献查询网站,可以通过页面中的“来源链接”跳转数据网站。
3、在猫眼课题宝点击“求助全文”按钮,发布文献应助需求时求助者需要支付50喵币作为应助成功后的答谢给应助者,发送到用助者账户中。若文献求助失败支付的50喵币将退还至求助者账户中。所支付的喵币仅作为答谢,而不是作为文献的“购买”费用,平台也不从中收取任何费用,
4、特别提醒用户通过求助获得的文献原文仅用户个人学习使用,不得用于商业用途,否则一切风险由用户本人承担;
5、本平台尊重知识产权,如果权利所有者认为平台内容侵犯了其合法权益,可以通过本平台提供的版权投诉渠道提出投诉。一经核实,我们将立即采取措施删除/下架/断链等措施。
我已知晓